Cellular biotechnology products and extracellular derivatives
Portfolio for clinical and institutional use. Each preparation is delivered with technical specifications, applicable controls and protocol integration advice.
Our production and release process
From source eligibility to released vial: SOP, traceability and cold chain, with predefined release criteria.
Source eligibility and screening
Selection according to criteria, consents and serology; case suitable for processing.
Laboratory processing
Isolation and expansion (cells) or purification (vesicles) under controlled conditions and traceability.
Characterization and release
Viability, identity/phenotype, sterility and endotoxins; in vesicles, particles and proteins; QA release.
Cryopreservation, documentation and delivery
Controlled freezing and storage; vial labeled with technical data sheet, traceability and, if applicable, certificate of quantification; cold chain shipment.
Our biotechnology products
Q-SUPPORT® EXOSOMES
(extracellular vesicles of MSC)
Purified preparation of vesicles 30-150 nm with a bioactive charge, for use as therapeutic adjunct in tissue repair and immunomodulation protocols.
- Origin and method. Characterized MSC derivatives; purification under controlled conditions.
- Characterization. CD63/CD81/CD9, size/count by NTA; sterility, mycoplasma and endotoxin testing.
- Use. Integration under protocol with scientific support for selection and management parameters.
Cell lines and derivatives with documented characterization
We develop and release cellular biomaterials for professional medical use.
Each line is characterized by defined markers and analytical tests, with technical documentation available and scientific support for its clinical implementation.
Stromal Precursors (MSC)
Mesenchymal cells characterized under the following criteria ISCTused as therapeutic adjunct for inflammatory and regenerative support in bone, joint and dermal tissues.
Dental Pulp Stem Cells (DPSC)
Population with mesenchymal profile obtained from human dental pulp, used in the manufacture of regenerative dentistry and oral and maxillofacial surgery. Application under defined protocol and specialized technical support.
Natural Killer (NK) Cells
Lymphocytes CD3-/CD56+ ex vivo expanded, with validated cytotoxic function and technical documentation per batch. Use under protocol in controlled clinical settings.